Cargando…
Development and prognosis of hepatocellular carcinoma in patients with diabetes
The incidence of diabetes mellitus and hepatocellular carcinoma (HCC) has been increasing worldwide during the last few decades, in the context of an increasing prevalence of obesity and non-alcoholic fatty liver disease (NAFLD). Epidemiologic studies have revealed that patients with diabetes have a...
Autores principales: | Nakatsuka, Takuma, Tateishi, Ryosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845683/ https://www.ncbi.nlm.nih.gov/pubmed/35903020 http://dx.doi.org/10.3350/cmh.2022.0095 |
Ejemplares similares
-
Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022) -
Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018) -
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023) -
Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018) -
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
por: Tateishi, Ryosuke, et al.
Publicado: (2021)